Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  epirubicin hydrochloride
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
Phase: Phase IV
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: P0334, NCI-2015-01391, NCT01501487
Pertuzumab and Trastuzumab with Combination Chemotherapy before Surgery in Treating Patients with Stage I-III HER2 Positive Breast Cancer
Phase: Phase II
Type: Treatment
Age: 18 to 65
Trial IDs: 1305012136, NCI-2015-02018, ML28772, NCT01855828
Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9464, NCI-2013-02414, NCT02050919
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients with Triple Negative Stage II-III Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 041401, NCI-2014-02029, NCT02315196
Molecular Profile-Directed Chemotherapy in Treating Patients with Metastatic HER2 Negative Esophagogastric Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-0973, NCI-2014-02639, NCT02358863
Start Over